Comparison Chart Ribomic Inc.

Stocks

4591

JP3974850004

Biotechnology & Medical Research

Delayed Japan Exchange 05:30:00 08/10/26 pm AEDT			5-day change	1st Jan Change
72.00 ^JPY	-2.70%		-10.00%	-7.69%

29/09	RIBOMIC, Inc. Announces No Safety Concerns After Three Months Of 1 Mg/Kg Weekly Treatment With Umedaptanib Pegol In Achondroplasia Phase 2 Study	CI
25/08	Ribomic Announces Completion of Clinical Trial Site Establishment for the Phase 3 Clinical Trial of Umedaptanib Pegol in Achondroplasia	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	RIBOMIC INC.	Bio Therapeutic Drugs	-2.70%	-10.00%	-7.69%	-25.00%	-78.70%	26.46M